Page 156 - 《南京医科大学学报（自然科学版）》2025年第9期

第45卷第9期
·1368 · 南 京 医 科 大 学 学 报 2025年9月

nies. However，the funding organizations did not participate in human metapneumovirus in children under 5 years in
the study design，literature collection and analysis，or the writ⁃ 2018：a systematic review and modelling study［J］. Lan⁃
ing of the manuscript. All authors declare that there are no eco⁃ cet Glob Health，2021，9（1）：e33-e43
nomic，personal，or other conflicts of interest related to this manu⁃ ［9］ WATSON A，WILKINSON T M A. Respiratory viral infec⁃
script，except for the aforementioned. tions in the elderly［J］. Ther Adv Respir Dis，2021，15：
作者贡献声明： 1753466621995050
辛亮负责构思文章的主题，进行文献检索与总结，设计 ［10］LI Z J，ZHANG H Y，REN L L，et al. Etiological and epi⁃
文章整体框架，撰写大部分内容。张岭负责关键研究的分 demiological features of acute respiratory infections in
析，协助撰写部分背景和结论。杨克俭负责审阅文章，深度 China［J］. Nat Commun，2021，12（1）：5026
分析，协助修改文章的最终版本。 ［11］PANDA S，MOHAKUD N K，PENA L，et al. Human meta⁃
Author’s Contributions： pneumovirus：review of an important respiratory patho⁃

XIN Liang conceived the topic of the article，conducted gen［J］. Int J Infect Dis，2014，25：45-52
literature review and summary，designed the overall framework ［12］HOWARD L. A little ⁃ known respiratory virus，hMPV，
of the article，and wrote the majority of the content. ZHANG surged this spring. What you need to know［EB/OL］.
Ling analyzed key studies and contributed to writing parts of the ［2024 ⁃ 08 ⁃ 28］. https：//health. ucdavis. edu/news/head⁃
background and conclusion sections. YANG Kejian reviewed lines/a⁃little⁃known⁃respiratory⁃virus⁃hmpv⁃surged⁃this⁃
the article，conducted in⁃depth analysis，and assisted in revising spring⁃what⁃you⁃need⁃to⁃know/2023/06
the final version of the manuscript. ［13］GUO L，LI L，LIU L，et al. Neutralising antibodies against
human metapneumovirus［J］. Lancet Microbe，2023，4
［参考文献］
（9）：e732-e744
［1］ VAN DEN HOOGEN B G，DE JONG J C，GROEN J，et ［14］MILLER R J，MOUSA J J. Structural basis for respiratory
al. A newly discovered human pneumovirus isolated from syncytial virus and human metapneumovirus neutraliza⁃
young children with respiratory tract disease［J］. Nat tion［J］. Curr Opin Virol，2023，61：101337
Med，2001，7（6）：719-724 ［15］HSIEH C L，RUSH S A，PALOMO C，et al. Structure ⁃
［2］ CHINESE CENTER FOR DISEASE CONTROL AND based design of prefusion⁃stabilized human metapneumov⁃
PREVENTION. What you should know about HMPV? irus fusion proteins［J］. Nat Commun，2022，13（1）：1299
［EB/OL］.［2024⁃11⁃25］. https：//en. chinacdc. cn/in_fo⁃ ［16］RUSH S A，BRAR G，HSIEH C L，et al. Characterization
cus/202306/t20230630_267503. html of prefusion⁃F⁃specific antibodies elicited by natural in⁃
［3］ GÁLVEZ N M S，ANDRADE C A，PACHECO G A，et al. fection with human metapneumovirus［J］. Cell Rep，2022，
Host components that modulate the disease caused by 40（12）：111399
hMPV［J］. Viruses，2021，13（3）：519 ［17］HUANG J C，DIAZ D，MOUSA J J. Antibody epitopes of
［4］ ZHOU Z，ZHANG P，CUI Y X，et al. Experiments investi⁃ pneumovirus fusion proteins［J］. Front Immunol，2019，
gating the competitive growth advantage of two different 10：2778
genotypes of human metapneumovirus：implications for ［18］FELDHAUS A，WOLF C，FIALA B，et al. A two⁃compo⁃
the alternation of genotype prevalence［J］. Sci Rep，2020， nent VLP vaccine platform for the development of a biva⁃

10（1）：2852 lent vaccine against RSV and hMPV：12th International
［5］ BALLEGEER M，SAELENS X. Cell⁃mediated responses RSV Symposium［C］. Northern Ireland：Wiley Blackwell，
to human metapneumovirus infection［J］. Viruses，2020， 2022
12（5）：542 ［19］ICOSAVAX. Icosavax announces positive topline interim
［6］ SKIADOPOULOS M H，BIACCHESI S，BUCHHOLZ U J， phase 1 results for bivalent VLP vaccine candidate IVX⁃
et al. The two major human metapneumovirus genetic lin⁃ A12 against RSV and hMPV in older adults［EB/OL］.
eages are highly related antigenically，and the fusion（F） （2023⁃05⁃22）［2024⁃12⁃04］. https：//ir. icosavax. com/
protein is a major contributor to this antigenic relatedness node/7836/pdf
［J］. J Virol，2004，78（13）：6927-6937 ［20］ICOSAVAX. Icosavax initiates phase 2 trial of IVX⁃A12
［7］ UDDIN S，THOMAS M. Human metapneumovirus［EB/ against RSV and hMPV in older adults［EB/OL］.（2023⁃06
OL］.［2024 ⁃ 09 ⁃ 29］. https：//www. ncbi. nlm. nih. gov/ ⁃20）［2024⁃10⁃15］. https：//ir. icosavax. com/news⁃releas⁃
books/NBK560910/ es/news⁃release⁃details/icosavax⁃initiates⁃phase⁃2⁃trial⁃
［8］ WANG X，LI Y，DELORIA⁃KNOLL M，et al. Global bur⁃ ivx⁃a12⁃against⁃rsv⁃and⁃hmpv
den of acute lower respiratory infection associated with ［21］MODERNA. Pediatric RSV + hMPV vaccine（mRNA ⁃